382 related articles for article (PubMed ID: 34190033)
1.
Duysburgh C; Van den Abbeele P; Morera M; Marzorati M
Benef Microbes; 2021 Aug; 12(4):59-73. PubMed ID: 34190033
[TBL] [Abstract][Full Text] [Related]
2.
Moens F; Duysburgh C; van den Abbeele P; Morera M; Marzorati M
Benef Microbes; 2019 Dec; 10(8):923-935. PubMed ID: 31965838
[TBL] [Abstract][Full Text] [Related]
3. Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
Waitzberg D; Guarner F; Hojsak I; Ianiro G; Polk DB; Sokol H
Adv Ther; 2024 Mar; 41(3):901-914. PubMed ID: 38286962
[TBL] [Abstract][Full Text] [Related]
4. Growth, survival, and metabolic activities of probiotics Lactobacillus rhamnosus GG and Saccharomyces cerevisiae var. boulardii CNCM-I745 in fermented coffee brews.
Chan MZA; Toh M; Liu SQ
Int J Food Microbiol; 2021 Jul; 350():109229. PubMed ID: 34023682
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.
Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP
Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989
[TBL] [Abstract][Full Text] [Related]
6. In vitro bioactivities of coffee brews fermented with the probiotics Lacticaseibacillus rhamnosus GG and Saccharomyces boulardii CNCM-I745.
Chan MZA; Lu Y; Liu SQ
Food Res Int; 2021 Nov; 149():110693. PubMed ID: 34600688
[TBL] [Abstract][Full Text] [Related]
7. Persistence of the Probiotic
Mahalak KK; Firrman J; Bobokalonov J; Narrowe AB; Bittinger K; Daniel S; Tanes C; Mattei LM; Zeng WB; Soares JW; Kobori M; Lemons JMS; Tomasula PM; Liu L
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361763
[TBL] [Abstract][Full Text] [Related]
8. Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline.
Roy Sarkar S; Mitra Mazumder P; Chatterjee K; Sarkar A; Adhikary M; Mukhopadhyay K; Banerjee S
Physiol Behav; 2021 Jul; 236():113411. PubMed ID: 33811908
[TBL] [Abstract][Full Text] [Related]
9. Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review.
Gopalan S; Ganapathy S; Mitra M; Neha ; Kumar Joshi D; Veligandla KC; Rathod R; Kotak BP
Cureus; 2023 Oct; 15(10):e46314. PubMed ID: 37927652
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive Probiotic
Gao G; Ma T; Zhang T; Jin H; Li Y; Kwok LY; Zhang H; Sun Z
Front Immunol; 2021; 12():772532. PubMed ID: 34970262
[TBL] [Abstract][Full Text] [Related]
11. Probiotics and antibiotic-associated diarrhea in children: A review and new evidence on Lactobacillus rhamnosus GG during and after antibiotic treatment.
Mantegazza C; Molinari P; D'Auria E; Sonnino M; Morelli L; Zuccotti GV
Pharmacol Res; 2018 Feb; 128():63-72. PubMed ID: 28827186
[TBL] [Abstract][Full Text] [Related]
12. Effect of
Toscano M; De Grandi R; Stronati L; De Vecchi E; Drago L
World J Gastroenterol; 2017 Apr; 23(15):2696-2704. PubMed ID: 28487606
[TBL] [Abstract][Full Text] [Related]
13. In Vitro and In Vivo Evaluation of Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis Bb12 Against Avian Pathogenic Escherichia coli and Identification of Novel Probiotic-Derived Bioactive Peptides.
Kathayat D; Closs G; Helmy YA; Deblais L; Srivastava V; Rajashekara G
Probiotics Antimicrob Proteins; 2022 Dec; 14(6):1012-1028. PubMed ID: 34458959
[TBL] [Abstract][Full Text] [Related]
14. Approach to probiotics in pediatrics: the role of Lactobacillus rhamnosus GG.
Boggio Marzet C; Burgos F; Del Compare M; Gerold I; Tabacco O; Vinderola G
Arch Argent Pediatr; 2022 Feb; 120(1):e1-e7. PubMed ID: 35068121
[TBL] [Abstract][Full Text] [Related]
15. Autoinducer-2 promotes the colonization of Lactobacillus rhamnosus GG to improve the intestinal barrier function in a neonatal mouse model of antibiotic-induced intestinal dysbiosis.
Hu R; Yang T; Ai Q; Shi Y; Ji Y; Sun Q; Tong B; Chen J; Wang Z
J Transl Med; 2024 Feb; 22(1):177. PubMed ID: 38369503
[TBL] [Abstract][Full Text] [Related]
16. Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome.
Cárdenas PA; Garcés D; Prado-Vivar B; Flores N; Fornasini M; Cohen H; Salvador I; Cargua O; Baldeón ME
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1365-1372. PubMed ID: 32125555
[TBL] [Abstract][Full Text] [Related]
17.
Briand F; Sulpice T; Giammarinaro P; Roux X
Benef Microbes; 2019 May; 10(5):555-567. PubMed ID: 31090460
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus rhamnosus attenuates Thai chili extracts induced gut inflammation and dysbiosis despite capsaicin bactericidal effect against the probiotics, a possible toxicity of high dose capsaicin.
Panpetch W; Visitchanakun P; Saisorn W; Sawatpanich A; Chatthanathon P; Somboonna N; Tumwasorn S; Leelahavanichkul A
PLoS One; 2021; 16(12):e0261189. PubMed ID: 34941893
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Anti-staphylococcal and Anti-inflammatory Abilities of Lacticaseibacillus rhamnosus from Infant Gut Microbiota as Potential Probiotic Against Infectious Women Mastitis.
Bousmaha-Marroki L; Boutillier D; Marroki A; Grangette C
Probiotics Antimicrob Proteins; 2021 Aug; 13(4):970-981. PubMed ID: 33649898
[TBL] [Abstract][Full Text] [Related]
20. Probiotics and prevention of Clostridium difficile infection.
Goldstein EJC; Johnson SJ; Maziade PJ; Evans CT; Sniffen JC; Millette M; McFarland LV
Anaerobe; 2017 Jun; 45():114-119. PubMed ID: 27988389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
